EphA2-targeted therapy delivers chemo directly to ovarian cancer cells
Wednesday, July 29, 2009 - 16:35
in Health & Medicine
HOUSTON - With a novel therapeutic delivery system, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center has successfully targeted a protein that is over-expressed in ovarian cancer cells.